Can pharmacoeconomic guidelines be implemented successfully in Asia? (editorial)

Title: Can pharmacoeconomic guidelines be implemented successfully in Asia? (editorial)
Creator: Li, Shu Chuen
Relation: Journal of Medical Economics Vol. 11, Issue 2, p. 341-343
Relation: http://informahealthcare.com/doi/abs/10.3111/13696990802221171
Publisher: Informa Healthcare
Resource Type: journal article
Date: 2008
Description: Since the introduction of the first Australian pharmaceoconomic guidelines in 1993, for the pharmaceutical industry to use when preparing a submission for public reimbursement of new drugs, there has been a gradual and accelerating proliferation of pharmacoeconomic guidelines internationally. Viewing the situation in Asia, there is actually a much stronger rationale for introducing and applying pharmacoeconomic evaluation in drug reimbursement decisions. Many Asian countries share the same concerns about high pharmaceutical expenditures and overuse of medicine due to the nature and funding arrangements of the healthcare system.
Subject: pharmacoeconomic guidelines; Asia; pharmaceutical industry; pharmaceutical expenditure; healthcare system
Identifier: http://hdl.handle.net/1959.13/43550
Identifier: uon:5645
Identifier: ISSN:1369-6998
Language: eng

		Thumbnail	File	Description	Size	Format